DBV Technologies S.A. buy phonebroker
Start price
23.10.17
/
50%
€49.22
Target price
30.10.17
€55.00
Performance (%)
-17.09%
End price
30.10.17
€40.81
Summary
This prediction ended on 30.10.17 with a price of €40.81. The price of DBV Technologies S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.09%. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| DBV Technologies S.A. | -6.869% | -6.869% | 329.878% | 36.416% |
| iShares Core DAX® | 1,07 % | -0,52 % | 9,66 % | 59,63 % |
| iShares Nasdaq 100 | -0,49 % | -4,06 % | -0,13 % | 84,64 % |
| iShares Nikkei 225® | -2,03 % | 6,91 % | 26,86 % | 64,58 % |
| iShares S&P 500 | -0,10 % | -2,37 % | 0,51 % | 58,34 % |
Comments by phonebroker for this prediction
In the thread DBV Technologies S.A. diskutieren
peanut allergy treatment fails to meet main goal in late-stage study
DBV Technologies peanut allergy treatment fails to meet main goal in late-stage study
Ein Tipp an sharewise:
Die Einschätzungen "anderer Mitglieder" sind Schrott, was sich mit meiner Empfehlung zu beweisen erscheint.
(Vom Mitglied beendet)